Treatment of OCD and ADHD When Escitalopram is Contraindicated

Introduction to Treatment Options

The American College of Cardiology is not relevant here, however, the International College of Obsessive-Compulsive Spectrum Disorders recommends sertraline as the first-line SSRI choice for OCD treatment, combined with cognitive-behavioral therapy (CBT) with exposure and response prevention (ERP), while addressing ADHD separately with stimulant medication 1

The National Institute for Health and Care Excellence recommends starting sertraline at 50 mg daily and titrating to maximum recommended or tolerated dose over at least 8 weeks for OCD treatment 1
The Canadian Psychiatric Association suggests combining sertraline with CBT consisting of patient and family psychoeducation and ERP for 10-20 sessions, as this combination shows superior outcomes compared to medication alone 1
The European College of Neuropsychopharmacology states that fluvoxamine, paroxetine, or fluoxetine are additional SSRI alternatives if sertraline is not tolerated, as all SSRIs have similar effect sizes for OCD treatment 1, 2
The World Health Organization indicates that no significant differences exist between SSRIs in efficacy for treating OCD, so the choice should be based on side effect profile, drug interactions, and past SSRI use 1, 2

The American Academy of Child and Adolescent Psychiatry recommends initiating stimulant medication (methylphenidate or amphetamines) as first-line treatment for ADHD, as these have 70-80% response rates and the largest effect sizes from over 161 randomized controlled trials 3
The National Institute of Mental Health suggests methylphenidate dosing: 5-20 mg three times daily for adults, or use extended-release formulations for once-daily dosing with maximum daily dose of 60 mg 3
The American Psychiatric Association recommends dextroamphetamine dosing: 5 mg three times daily to 20 mg twice daily for adults 4, 5, 6

The American Medical Association states that atomoxetine (60-100 mg daily) is the only FDA-approved non-stimulant for adult ADHD and should be considered if stimulants are contraindicated or not tolerated, though it requires 2-4 weeks to achieve full effect 3
The European Society for the Study of Anxiety Disorders suggests guanfacine (1-4 mg daily) or clonidine are FDA-approved alternatives, particularly useful when sleep disturbances, tics, or disruptive behavior disorders are present 3

The International Society for Research on Impulse Disorders recommends scheduling follow-up in 2-4 weeks initially to assess medication tolerability and early response 7
The American Heart Association suggests monitoring blood pressure and pulse at baseline and regularly during stimulant treatment 3
The National Alliance on Mental Illness recommends tracking OCD symptom severity using standardized scales (such as Yale-Brown Obsessive Compulsive Scale) at baseline and throughout treatment 1
The World Psychiatric Association indicates that maintaining SSRI treatment for at least 12-24 months after achieving remission to prevent OCD relapse is recommended 1, 7